Breakthrough Single-Cell Biophysical Platform

>100x more precise than conventional methods

Label-free cellular analysis

Multiparametric measurements

Universal applications across cell types

Scalable and rapid platform technology

Our MIT-invented technology measures cellular responses with unprecedented precision, enabling insights that were previously impossible to obtain.

Key Advantages

Why Cellular Biometrics?

Superior Analysis:
- Direct measurement of cellular response
- Functional interrogation of cellular phenotype
- Robust application across cancer and immune cells
- Rapid results, with precision insight
- Comprehensive cellular analysis

Clinical Benefits:
- Enhanced personalized therapy selection
- Unique accounting of clinical outliers
- Reduced treatment failures
- Faster time to optimal therapy
- Cost-effective analysis
- Universal application

Validation Data

Proven Clinical Impact

Key Results:
- Predictive response rates outperform guidelines 3-fold
- Validated in >80% of recognized cancer type
- Well over 1000 clinical samples analyzed in CLIA lab
- Multiple peer-reviewed publications
- Ongoing clinical studies
- Utilized in many top tier US and Canadian Centers

Future Capabilities

Expanding the Boundaries of Personalized Medicine

Pipeline:
- Unmatched immunotherapy response prediction
- Blood-based and highly scalable
- Clinical questions in cancer beyond immunotherapy
- Expansive opportunities in all areas of immunity
- Novel biomarker development
- AI/ML integration opportunites